Compare · BG vs MED
BG vs MED
Side-by-side comparison of Bunge Limited (BG) and MEDIFAST INC (MED): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BG and MED operate in Packaged Foods (Consumer Staples), so they compete in similar markets.
- BG is the larger of the two at $21.46B, about 157.9x MED ($136.0M).
- Both names hit the wire about 6 times in the past 4 weeks.
- BG has more recent analyst coverage (25 ratings vs 7 for MED).
- Company
- Bunge Limited
- MEDIFAST INC
- Price
- -
- -
- Market cap
- $21.46B
- $136.0M
- 1M return
- -
- +21.99%
- 1Y return
- -
- -12.59%
- Industry
- Packaged Foods
- Packaged Foods
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 6
- 6
- Recent ratings
- 25
- 7
Bunge Limited
Bunge Limited operates as an agribusiness and food company worldwide. It operates through five segments: Agribusiness, Edible Oil Products, Milling Products, Fertilizer, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains primarily wheat and corn; and vegetable oils and protein meals. It provides its products for animal feed manufacturers, livestock producers, wheat and corn millers, and other oilseed processors, as well as third-party edible oil processing companies; and for industrial and biodiesel production applications. The Edible Oil Products segment provides packaged and bulk oils and fats, including cooking oils, shortenings, margarines, mayonnaise, and others for baked goods companies, snack food producers, confectioners, restaurant chains, foodservice operators, infant nutrition companies, and other food manufacturers, as well as grocery chains, wholesalers, distributors, and other retailers. The Milling Products segment offers wheat flours and bakery mixes; corn milling products that include dry-milled corn meals and flours, wet-milled masa and flours, and flaking and brewer's grits, as well as soy-fortified corn meal, corn-soy blends, and other products; and whole grain and fiber ingredients. The Fertilizer segment offers nitrogen, phosphate, and potassium fertilizers; and SSP, ammonia, ammonium thiosulfate, monoammonium phosphate, diammonium phosphate, triple superphosphate, urea, urea-ammonium nitrate, ammonium sulfate, and potassium chloride. The Sugar and Bioenergy segment produces sugar and ethanol; and generates electricity from burning sugarcane bagasse. The company was founded in 1818 and is headquartered in St. Louis, Missouri.
MEDIFAST INC
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and its franchisee system. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Latest BG
- Bunge to Present at Barclays Annual Global Consumer Conference
- Bunge Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Bunge Global SA Announces Pricing of $600 Million Senior Notes Offering
- SEC Form FWP filed by Bunge Limited
- SEC Form 424B3 filed by Bunge Limited
- Director Mahoney Christopher bought $689,050 worth of shares (6,500 units at $106.01), increasing direct ownership by 78% to 14,820 units (SEC Form 4)
- SEC Form 10-Q filed by Bunge Limited
- Bunge Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Bunge Reports Second Quarter 2026 Results
- Bunge Schedules Second Quarter 2026 Earnings Release and Conference Call
Latest MED
- Director Kiai Parsa bought $842,699 worth of shares (72,487 units at $11.63) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by MEDIFAST INC
- SEC Form S-8 filed by MEDIFAST INC
- SEC Form 10-Q filed by MEDIFAST INC
- MEDIFAST INC filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Medifast Announces Second Quarter 2026 Financial Results
- Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
- MEDIFAST INC filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
- Amendment: New insider Kiai Parsa claimed ownership of 607,796 shares (SEC Form 3)